Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 160.7 M137.5 M196.1 M219.7 M227 M242 M 884.8 M Research & development —————— — Operating income 25.4 M83.1 M114.6 M128.4 M50 M95 M 388 M Non-Operating Income, Total 11.5 M15.9 M16.1 M6.5 M3 M7 M 32.6 M Interest expense, net of interest capitalized 28.5 M39.4 M60.8 M61.3 M65 M65 M 252.1 M Non-Operating Income, excl. Interest Expenses -15.8 M-20.5 M-43.3 M-51.2 M-60 M-60 M -214.5 M Unusual income/expense -1.2 M-3 M-1.4 M-3.6 M-2 M2 M -5 M Pretax income 11.4 M55.7 M60.5 M67.5 M-12 M37 M 153 M Equity in earnings —————— — Taxes -8.1 M14.6 M27.1 M14.9 M-24 M13 M 31 M Non-controlling/minority interest 2.8 M7.1 M5.3 M12.7 M-3 M2 M 17 M After tax other income/expense 0000—— — Net income before discontinued operations 16.7 M34 M28.1 M39.9 M15 M22 M 105 M Discontinued operations —————— — Net income 16.7 M34 M28.1 M39.9 M15 M22 M 105 M Dilution adjustment 1.7 M4.5 M2.8 M7.8 M-1 M7 M 16.6 M Preferred dividends 09.5 M15.1 M14.9 M16 M15 M 61 M Diluted net income available to common stockholders 38 M29 M15.8 M32.8 M-2 M14 M 60.6 M Basic earnings per share (Basic EPS) 0.480.70.380.3700.08 0.64 Diluted earnings per share (Diluted EPS) 0.40.640.3629.9200.08 0.72 Average basic shares outstanding 69.15 M68.47 M68.5 M66.73 M73.64 M76.48 M — Diluted shares outstanding 92.16 M90.85 M90.87 M87.62 M73.64 M77.02 M — EBITDA 96.3 M151.9 M223.7 M230.7 M165 M204 M 823.4 M EBIT 11.1 M63.5 M98.6 M96.8 M30 M65 M 290.4 M Cost of revenue 620.5 M704.5 M787.2 M781.8 M770 M894 M 3.23 B Other cost of goods sold 591.3 M673.7 M747.9 M739.1 M729 M849 M 3.06 B Depreciation & amortization (cash flow) 85.2 M88.4 M125.1 M133.9 M135 M139 M 533 M